Inventor · disambiguated record
William Michael Flanagan
Also filed as: FLANAGAN WILLIAM M · FLANAGAN WILLIAM MICHAEL
9 granted patents·2 pending applications·132 citations·filing 1995–2022
89Inventor score
Files withSIRNA THERAPEUTICS INC4UNIV LELAND STANFORD JUNIOR3GENENTECH INC2BUTORA GABOR1SUNESIS PHARMACEUTICALS INC1
Top patents by PatentIndex Score
11 records- 0194US9970005B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2015·Granted May 15, 2018·15 cites·41 claims
- 0293US11932854B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2021·Granted Mar 19, 2024·2 cites·25 claims
- 0391US11193126B2RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)SIRNA THERAPEUTICS INC·Filed 2018·Granted Dec 7, 2021·7 cites·40 claims
- 0491US6875571B2NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agentsUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Apr 5, 2005·36 cites·21 claims
- 0590US8877439B2Method for rapidly evaluating performance of short interfering RNA with novel chemical modificationsBUTORA GABOR·Filed 2010·Granted Nov 4, 2014·22 cites·18 claims
- 0679US9512426B2Method for rapidly evaluating performance of short interfering RNA with novel chemical modificationsSIRNA THERAPEUTICS INC·Filed 2014·Granted Dec 6, 2016·2 cites·18 claims
- 0777US6376524B1Triphenyl compounds as interleukin-4 antagonistsSUNESIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 23, 2002·14 cites·15 claims
- 0864US6352830B1NF-AT polypeptides and polynucleotides and screening methods for immunosuppressive agentsUNIV LELAND STANFORD JUNIOR·Filed 1999·Granted Mar 5, 2002·23 cites·21 claims
- 0955US2022324981A1Dosing for treatment with anti-tigit and anti-pd-l1 antagonist antibodiesGENENTECH INC·Filed 2022·Application pending·0 cites
- 1048US5989810AScreening methods for immunosuppressive agentsUNIV LELAND STANFORD JUNIOR·Filed 1995·Granted Nov 23, 1999·11 cites·7 claims
- 1148US2022098318A1Dosing for treatment with anti-tigit and anti-cd20 or anti-cd38 antibodiesGENENTECH INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when William Michael Flanagan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →